Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 405

1.

Spatial judgment in Parkinson's disease: Contributions of attentional and executive dysfunction.

Salazar RD, Moon KLM, Neargarder S, Cronin-Golomb A.

Behav Neurosci. 2019 Aug;133(4):350-360. doi: 10.1037/bne0000329.

PMID:
31294590
2.

Digestibility and Acceptability of Wheat Flour Cookies Partially Substituted with High Amylose Maize Starch.

Ortíz-Fernández MP, Castillo-Ruiz O, Velazquez G, Aleman-Castillo SE, Salazar RR, Osorio-Díaz P, Mendez-Montealvo G.

Plant Foods Hum Nutr. 2019 Jul 4. doi: 10.1007/s11130-019-00753-7. [Epub ahead of print]

PMID:
31273640
3.

Carcinoembryonic Antigen Levels and Survival in Stage III Colon Cancer: Post hoc Analysis of the MOSAIC and PETACC-8 Trials.

Auclin E, Taieb J, Lepage C, Aparicio T, Faroux R, Mini E, Folprecht G, Salazar R, Benetkiewicz M, Banzi M, Louvet C, Van Laethem JL, Tabernero J, Hickish T, de Gramont A, André T, Vernerey D.

Cancer Epidemiol Biomarkers Prev. 2019 Jul;28(7):1153-1161. doi: 10.1158/1055-9965.EPI-18-0867.

PMID:
31263053
4.

Comparison and applicability of molecular classifications for gastric cancer.

Serra O, Galán M, Ginesta MM, Calvo M, Sala N, Salazar R.

Cancer Treat Rev. 2019 Jul;77:29-34. doi: 10.1016/j.ctrv.2019.05.005. Epub 2019 May 28. Review.

PMID:
31195213
5.

Population study of thrombophilic markers and pharmacogenetic markers of warfarin prevalence in Bosnia and Herzegovina.

Ašić A, Salazar R, Storm N, Doğan S, Höppner W, Marjanović D, Primorac D.

Croat Med J. 2019 Jun 13;60(3):212-220.

6.

Effects of Age Among Elderly Cancer Patients on Breakthrough Pain Management with Sublingual Fentanyl Tablets.

Guitart J, Vargas MI, De Sanctis V, Folch J, Salazar R, Fuentes J, Coma J, Ferreras J, Moya J, Tomás A, Estivill P, Rodelas F, Jiménez AJ, Sanz A.

Drugs R D. 2019 Jun 8. doi: 10.1007/s40268-019-0276-x. [Epub ahead of print]

PMID:
31177479
7.

High prevalence of CTX-M-1 group in ESBL-producing enterobacteriaceae infection in intensive care units in southern Chile.

Pavez M, Troncoso C, Osses I, Salazar R, Illesca V, Reydet P, Rodríguez C, Chahin C, Concha C, Barrientos L.

Braz J Infect Dis. 2019 Mar - Apr;23(2):102-110. doi: 10.1016/j.bjid.2019.03.002. Epub 2019 Apr 24.

8.

Noncanonical TGFβ Pathway Relieves the Blockade of IL1β/TGFβ-Mediated Crosstalk between Tumor and Stroma: TGFBR1 and TAK1 Inhibition in Colorectal Cancer.

Guillén Díaz-Maroto N, Sanz-Pamplona R, Berdiel-Acer M, Cimas FJ, García E, Gonçalves-Ribeiro S, Albert N, Garcia-Vicién G, Capella G, Moreno V, Salazar R, Villanueva A, Molleví DG.

Clin Cancer Res. 2019 Jul 15;25(14):4466-4479. doi: 10.1158/1078-0432.CCR-18-3957. Epub 2019 Apr 12.

PMID:
30979739
9.

Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial.

Santos C, Azuara D, Viéitez JM, Páez D, Falcó E, Élez E, López-López C, Valladares M, Robles-Díaz L, García-Alfonso P, Bugés C, Durán G, Salud A, Navarro V, Capellá G, Aranda E, Salazar R.

Ann Oncol. 2019 May 1;30(5):796-803. doi: 10.1093/annonc/mdz082.

PMID:
30840064
10.

Context matters-consensus molecular subtypes of colorectal cancer as biomarkers for clinical trials.

Fontana E, Eason K, Cervantes A, Salazar R, Sadanandam A.

Ann Oncol. 2019 Apr 1;30(4):520-527. doi: 10.1093/annonc/mdz052.

11.

A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE).

Machiels JP, Salazar R, Rottey S, Duran I, Dirix L, Geboes K, Wilkinson-Blanc C, Pover G, Alvis S, Champion B, Fisher K, McElwaine-Johnn H, Beadle J, Calvo E.

J Immunother Cancer. 2019 Jan 28;7(1):20. doi: 10.1186/s40425-019-0510-7.

12.

Ultra-selection of metastatic colorectal cancer patients using next-generation sequencing to improve clinical efficacy of anti-EGFR therapy.

Vidal J, Bellosillo B, Santos Vivas C, García-Alfonso P, Carrato A, Cano MT, García-Carbonero R, Élez E, Losa F, Massutí B, Valladares-Ayerbes M, Viéitez JM, Manzano JL, Azuara D, Gallego J, Pairet S, Capellá G, Salazar R, Tabernero J, Aranda E, Montagut C.

Ann Oncol. 2019 Mar 1;30(3):439-446. doi: 10.1093/annonc/mdz005.

PMID:
30689692
13.

In seedlings of Pinus radiata, jasmonic acid and auxin are differentially distributed on opposite sides of tilted stems affecting lignin monomer biosynthesis and composition.

Salazar R, Pollmann S, Morales-Quintana L, Herrera R, Caparrós-Ruiz D, Ramos P.

Plant Physiol Biochem. 2019 Feb;135:215-223. doi: 10.1016/j.plaphy.2018.12.008. Epub 2018 Dec 15.

PMID:
30576980
14.

Delusional Misidentification Syndrome: Phantom Boarder Syndrome Presenting With Intact General Cognition and Functional Brain Imaging Evidence of Bilateral Posterior and Orbitofrontal Hypometabolism.

Lek SJ, Trinh S, Gavito-Higuera J, Salazar R.

J Neuropsychiatry Clin Neurosci. Spring 2019;31(2):175-177. doi: 10.1176/appi.neuropsych.18080185. Epub 2018 Dec 18. No abstract available.

PMID:
30561281
15.

Fenton-based electrochemical degradation of metolachlor in aqueous solution by means of BDD and Pt electrodes: influencing factors and reaction pathways.

Thiam A, Salazar R.

Environ Sci Pollut Res Int. 2019 Jan;26(3):2580-2591. doi: 10.1007/s11356-018-3768-2. Epub 2018 Nov 24.

PMID:
30474812
16.

The Efficacy of an Antioppression Curriculum for Health Professionals.

Wu D, Saint-Hilaire L, Pineda A, Hessler D, Saba GW, Salazar R, Olayiwola N.

Fam Med. 2019 Jan 7;51(1):22-30. doi: 10.22454/FamMed.2018.227415.

PMID:
30412265
17.

Comparison of methohexital and propofol as induction agents for evaluation of laryngeal function in healthy dogs.

Brown MB, Dugat DR, Lyon SD, Nafe LA, Payton ME, Peakheart SK, Salazar RS.

Vet Surg. 2019 Jan;48(1):70-78. doi: 10.1111/vsu.13110. Epub 2018 Oct 27.

18.

Predictors of self-perceived stigma in Parkinson's disease.

Salazar RD, Weizenbaum E, Ellis TD, Earhart GM, Ford MP, Dibble LE, Cronin-Golomb A.

Parkinsonism Relat Disord. 2019 Mar;60:76-80. doi: 10.1016/j.parkreldis.2018.09.028. Epub 2018 Sep 25.

PMID:
30297211
19.

A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma Patients.

García M, Moreno R, Gil-Martin M, Cascallò M, de Olza MO, Cuadra C, Piulats JM, Navarro V, Domenech M, Alemany R, Salazar R.

Hum Gene Ther. 2019 Mar;30(3):352-364. doi: 10.1089/hum.2018.107. Epub 2018 Nov 13.

PMID:
30234393
20.

Molecular Subtypes and the Evolution of Treatment Decisions in Metastatic Colorectal Cancer.

Dienstmann R, Salazar R, Tabernero J.

Am Soc Clin Oncol Educ Book. 2018 May 23;38:231-238. doi: 10.1200/EDBK_200929. Review.

PMID:
30231342
21.

A phase I trial of oncolytic adenovirus ICOVIR-5 administered intravenously to melanoma patients.

Garcia M, Moreno R, Gil M, Cascallo M, de Olza MO, Cuadra C, Piulat JM, Navarro V, Domenech M, Alemany R, Salazar R.

Hum Gene Ther Clin Dev. 2018 Sep 18. doi: 10.1089/humc.2018.107. [Epub ahead of print]

PMID:
30226396
22.

Restoring wild-type-like CA1 network dynamics and behavior during adulthood in a mouse model of schizophrenia.

Marissal T, Salazar RF, Bertollini C, Mutel S, De Roo M, Rodriguez I, Müller D, Carleton A.

Nat Neurosci. 2018 Oct;21(10):1412-1420. doi: 10.1038/s41593-018-0225-y. Epub 2018 Sep 17.

PMID:
30224804
23.

Co-ocurrence of neurosarcoidosis and intrathecal reactivation of Epstein-Barr virus.

Salazar R, Hypolite T, Bixby E, Nguyen A.

Mult Scler Relat Disord. 2018 Oct;25:297-299. doi: 10.1016/j.msard.2018.08.021. Epub 2018 Aug 24. No abstract available.

PMID:
30172172
24.

Eye movement control during visual pursuit in Parkinson's disease.

Wu CC, Cao B, Dali V, Gagliardi C, Barthelemy OJ, Salazar RD, Pomplun M, Cronin-Golomb A, Yazdanbakhsh A.

PeerJ. 2018 Aug 22;6:e5442. doi: 10.7717/peerj.5442. eCollection 2018.

25.

Unmet Medical Needs in Metastatic Lung and Digestive Neuroendocrine Neoplasms.

Capdevila J, Bodei L, Davies P, Gorbounova V, Jensen RT, Knigge UP, Krejs GJ, Krenning E, O'Connor JM, Peeters M, Rindi G, Salazar R, Vullierme MP, Pavel ME; ENETS 2016 Munich Advisory Board Participants; ENETS 2016 Munich Advisory Board Participants.

Neuroendocrinology. 2019;108(1):18-25. doi: 10.1159/000493319. Epub 2018 Aug 28.

26.

Competencies of the nurse in educational institutions: a look from educational managers.

Mori FMLV, Edquen SB, Espinoza ZEL, Salazar RS.

Rev Gaucha Enferm. 2018 Aug 2;39:e20170152. doi: 10.1590/1983-1447.2018.2017-0152. Spanish, English.

27.

On the performance of electrocatalytic anodes for photoelectro-Fenton treatment of synthetic solutions and real water spiked with the herbicide chloramben.

Thiam A, Sirés I, Salazar R, Brillas E.

J Environ Manage. 2018 Oct 15;224:340-349. doi: 10.1016/j.jenvman.2018.07.065. Epub 2018 Jul 23.

PMID:
30056353
28.

Correction to: Efficacy and Safety of Sublingual Fentanyl Tablets in Breakthrough Cancer Pain Management According to Cancer Stage and Background Opioid Medication.

Guitart J, Vargas MI, De Sanctis V, Folch J, Salazar R, Fuentes J, Coma J, Ferreras J, Moya J, Tomás A, Estivill P, Rodelas F, Jiménez AJ, Sanz A.

Drugs R D. 2018 Sep;18(3):247-248. doi: 10.1007/s40268-018-0239-7.

29.

Ambulatory function in spinal muscular atrophy: Age-related patterns of progression.

Montes J, McDermott MP, Mirek E, Mazzone ES, Main M, Glanzman AM, Duong T, Young SD, Salazar R, Pasternak A, Gee R, De Sanctis R, Coratti G, Forcina N, Fanelli L, Ramsey D, Milev E, Civitello M, Pane M, Pera MC, Scoto M, Day JW, Tennekoon G, Finkel RS, Darras BT, Muntoni F, De Vivo DC, Mercuri E.

PLoS One. 2018 Jun 26;13(6):e0199657. doi: 10.1371/journal.pone.0199657. eCollection 2018.

30.

Quantitative Evaluation of Lower Extremity Joint Contractures in Spinal Muscular Atrophy: Implications for Motor Function.

Salazar R, Montes J, Dunaway Young S, McDermott MP, Martens W, Pasternak A, Quigley J, Mirek E, Glanzman AM, Civitello M, Gee R, Duong T, Mazzone ES, Main M, Mayhew A, Ramsey D, Muni Lofra R, Coratti G, Fanelli L, De Sanctis R, Forcina N, Chiriboga C, Darras BT, Tennekoon GI, Scoto M, Day JW, Finkel R, Muntoni F, Mercuri E, De Vivo DC.

Pediatr Phys Ther. 2018 Jul;30(3):209-215. doi: 10.1097/PEP.0000000000000515.

PMID:
29924070
31.

Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR Study.

Capdevila J, Teulé A, Barriuso J, Castellano D, Lopez C, Manzano JL, Alonso V, García-Carbonero R, Dotor E, Matos I, Custodio A, Casanovas O, Salazar R; EVERLAR study investigators.

Oncologist. 2019 Jan;24(1):38-46. doi: 10.1634/theoncologist.2017-0622. Epub 2018 May 23.

PMID:
29794066
32.

Treatment of winery wastewater by anodic oxidation using BDD electrode.

Candia-Onfray C, Espinoza N, Sabino da Silva EB, Toledo-Neira C, Espinoza LC, Santander R, García V, Salazar R.

Chemosphere. 2018 Sep;206:709-717. doi: 10.1016/j.chemosphere.2018.04.175. Epub 2018 May 4.

PMID:
29783056
33.

Degradation of ampicillin antibiotic by electrochemical processes: evaluation of antimicrobial activity of treated water.

Vidal J, Huiliñir C, Santander R, Silva-Agredo J, Torres-Palma RA, Salazar R.

Environ Sci Pollut Res Int. 2019 Feb;26(5):4404-4414. doi: 10.1007/s11356-018-2234-5. Epub 2018 May 17.

PMID:
29770941
34.

Depolymerization of Trityl End-Capped Poly(Ethyl Glyoxylate): Potential Applications in Smart Packaging.

Fan B, Salazar R, Gillies ER.

Macromol Rapid Commun. 2018 Jun;39(11):e1800173. doi: 10.1002/marc.201800173. Epub 2018 Apr 26.

PMID:
29700924
35.

RET-fusions: a novel paradigm in colorectal cancer.

Santos C, Sanz-Pamplona R, Salazar R.

Ann Oncol. 2018 Jun 1;29(6):1340-1343. doi: 10.1093/annonc/mdy132. No abstract available.

PMID:
29648570
36.

Effective removal of the antibiotic Nafcillin from water by combining the Photoelectro-Fenton process and Anaerobic Biological Digestion.

Vidal J, Huiliñir C, Santander R, Silva-Agredo J, Torres-Palma RA, Salazar R.

Sci Total Environ. 2018 May 15;624:1095-1105. doi: 10.1016/j.scitotenv.2017.12.159. Epub 2017 Dec 27.

PMID:
29625524
37.

Efficacy and Safety of Sublingual Fentanyl Tablets in Breakthrough Cancer Pain Management According to Cancer Stage and Background Opioid Medication.

Guitart J, Vargas MI, De Sanctis V, Folch J, Salazar R, Fuentes J, Coma J, Ferreras J, Moya J, Tomás A, Estivill P, Rodelas F, Jiménez AJ, Sanz A.

Drugs R D. 2018 Jun;18(2):119-128. doi: 10.1007/s40268-018-0231-2. Erratum in: Drugs R D. 2018 Sep;18(3):247-248.

38.

Atypical presentation of probable Creutzfeldt-Jakob disease associated with anti-Zic4 antibody: Literature review of neuronal antibodies in Creutzfeldt-Jakob disease.

Salazar R.

Clin Neurol Neurosurg. 2018 May;168:72-76. doi: 10.1016/j.clineuro.2018.02.043. Epub 2018 Mar 5.

PMID:
29525731
39.

Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses: A Phase 2 Randomized Clinical Trial.

Montagut C, Argilés G, Ciardiello F, Poulsen TT, Dienstmann R, Kragh M, Kopetz S, Lindsted T, Ding C, Vidal J, Clausell-Tormos J, Siravegna G, Sánchez-Martín FJ, Koefoed K, Pedersen MW, Grandal MM, Dvorkin M, Wyrwicz L, Rovira A, Cubillo A, Salazar R, Desseigne F, Nadal C, Albanell J, Zagonel V, Siena S, Fumi G, Rospo G, Nadler P, Horak ID, Bardelli A, Tabernero J.

JAMA Oncol. 2018 Apr 12;4(4):e175245. doi: 10.1001/jamaoncol.2017.5245. Epub 2018 Apr 12. Erratum in: JAMA Oncol. 2019 May 1;5(5):745.

40.

Electrochemical degradation of industrial textile dye disperse yellow 3: Role of electrocatalytic material and experimental conditions on the catalytic production of oxidants and oxidation pathway.

Salazar R, Ureta-Zañartu MS, González-Vargas C, Brito CDN, Martinez-Huitle CA.

Chemosphere. 2018 May;198:21-29. doi: 10.1016/j.chemosphere.2017.12.092. Epub 2017 Dec 28.

PMID:
29421732
41.

Circulating cell-free DNA as predictor of treatment failure after neoadjuvant chemoradiotherapy before surgery in patients with locally advanced rectal cancer: is it ready for primetime?

Vivancos A, Élez E, Salazar R.

Ann Oncol. 2018 Mar 1;29(3):532-534. doi: 10.1093/annonc/mdy043. No abstract available.

PMID:
29401228
42.

Trypanosoma cruzi Infection Does Not Decrease Survival or Reproduction of the Common Bed Bug, Cimex lectularius.

Peterson JK, Salazar R, Castillo-Neyra R, Borrini-Mayori K, Condori C, Bartow-McKenney C, Tracy D, Náquira C, Levy MZ.

Am J Trop Med Hyg. 2018 Mar;98(3):724-734. doi: 10.4269/ajtmh.17-0593. Epub 2018 Jan 18.

43.

Exact mean-energy expansion of Ginibre's gas for coupling constants Γ=2×(oddinteger).

Salazar R, Téllez G.

Phys Rev E. 2017 Dec;96(6-1):062145. doi: 10.1103/PhysRevE.96.062145. Epub 2017 Dec 26.

PMID:
29347313
44.

Search for Neutrinoless Quadruple-β Decay of ^{150}Nd with the NEMO-3 Detector.

Arnold R, Augier C, Barabash AS, Basharina-Freshville A, Blondel S, Blot S, Bongrand M, Boursette D, Brudanin V, Busto J, Caffrey AJ, Calvez S, Cascella M, Cerna C, Cesar JP, Chapon A, Chauveau E, Chopra A, Dawson L, Duchesneau D, Durand D, Egorov V, Eurin G, Evans JJ, Fajt L, Filosofov D, Flack R, Garrido X, Gómez H, Guillon B, Guzowski P, Hodák R, Huber A, Hubert P, Hugon C, Jullian S, Klimenko A, Kochetov O, Konovalov SI, Kovalenko V, Lalanne D, Lang K, Lemière Y, Le Noblet T, Liptak Z, Liu XR, Loaiza P, Lutter G, Macko M, Macolino C, Mamedov F, Marquet C, Mauger F, Morgan B, Mott J, Nemchenok I, Nomachi M, Nova F, Nowacki F, Ohsumi H, Patrick C, Pahlka RB, Perrot F, Piquemal F, Povinec P, Přidal P, Ramachers YA, Remoto A, Reyss JL, Riddle CL, Rukhadze E, Saakyan R, Salazar R, Sarazin X, Shitov Y, Simard L, Šimkovic F, Smetana A, Smolek K, Smolnikov A, Söldner-Rembold S, Soulé B, Štefánik D, Štekl I, Suhonen J, Sutton CS, Szklarz G, Thomas J, Timkin V, Torre S, Tretyak VI, Tretyak VI, Umatov VI, Vanushin I, Vilela C, Vorobel V, Waters D, Xie F, Žukauskas A; NEMO-3 Collaboration.

Phys Rev Lett. 2017 Jul 28;119(4):041801. doi: 10.1103/PhysRevLett.119.041801. Epub 2017 Jul 24.

PMID:
29341770
45.

Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Naïve Advanced Pancreatic Neuroendocrine Tumors.

Salazar R, Garcia-Carbonero R, Libutti SK, Hendifar AE, Custodio A, Guimbaud R, Lombard-Bohas C, Ricci S, Klümpen HJ, Capdevila J, Reed N, Walenkamp A, Grande E, Safina S, Meyer T, Kong O, Salomon H, Tavorath R, Yao JC.

Oncologist. 2018 Jul;23(7):766-e90. doi: 10.1634/theoncologist.2017-0144. Epub 2017 Dec 14.

46.

Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational Status.

Taieb J, Kourie HR, Emile JF, Le Malicot K, Balogoun R, Tabernero J, Mini E, Folprecht G, Van Laethem JL, Mulot C, Bouché O, Aparicio T, Michel P, Thaler J, Bridgewater J, Van Cutsem E, Perkins G, Lepage C, Salazar R, Laurent-Puig P; Pan-European Trials in Alimentary Tract Cancer (PETACC)-8 Investigators.

JAMA Oncol. 2018 Jul 12;4(7):e173695. doi: 10.1001/jamaoncol.2017.3695. Epub 2018 Jul 12.

47.

Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial.

Abad A, Martínez-Balibrea E, Viéitez JM, Alonso-Orduña V, García Alfonso P, Manzano JL, Massutí B, Benavides M, Carrato A, Zanui M, Gallego J, Grávalos C, Conde V, Provencio M, Valladares-Ayerbes M, Salazar R, Sastre J, Montagut C, Rivera F, Aranda E.

Ann Oncol. 2018 Feb 1;29(2):439-444. doi: 10.1093/annonc/mdx737.

PMID:
29145602
48.

Factors Predicting Adherence to a Tailored-Dose Adjuvant Treatment on the Basis of Geriatric Assessment in Elderly People With Colorectal Cancer: A Prospective Study.

Antonio M, Carmona-Bayonas A, Saldaña J, Navarro V, Tebé C, Salazar R, Borràs JM.

Clin Colorectal Cancer. 2018 Mar;17(1):e59-e68. doi: 10.1016/j.clcc.2017.09.003. Epub 2017 Sep 28.

PMID:
29054805
49.

DPYD genotype-guided fluoropyrimidines dose: is it ready for prime time?

Páez D, Salazar R, Tabernero J.

Ann Oncol. 2017 Dec 1;28(12):2913-2914. doi: 10.1093/annonc/mdx632. No abstract available.

PMID:
29045550
50.

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial.

Tawbi HA, Burgess M, Bolejack V, Van Tine BA, Schuetze SM, Hu J, D'Angelo S, Attia S, Riedel RF, Priebat DA, Movva S, Davis LE, Okuno SH, Reed DR, Crowley J, Butterfield LH, Salazar R, Rodriguez-Canales J, Lazar AJ, Wistuba II, Baker LH, Maki RG, Reinke D, Patel S.

Lancet Oncol. 2017 Nov;18(11):1493-1501. doi: 10.1016/S1470-2045(17)30624-1. Epub 2017 Oct 4. Erratum in: Lancet Oncol. 2017 Dec;18(12 ):e711. Erratum in: Lancet Oncol. 2018 Jan;19(1):e8.

PMID:
28988646

Supplemental Content

Loading ...
Support Center